Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows provided by operating activities:
Net (loss) income	$ (179)	$ 649
Adjustments to reconcile net (loss) income to net cash from operating activities:
Depreciation and amortization	100	97
Accretion of financing instruments and other non cash interest	26	26
Stock based compensation	4	4
Change in valuation allowance of deferred tax assets	(54)
Impairment charge on investment in iBio, Inc.	83
Change in fair value of derivative liabilities	118	368
Changes in operating assets and liabilities:
Accounts receivable	1,347	(630)
Inventories	603	(324)
Other current assets	35	17
Security deposits and other assets	(48)
Accounts payable	(455)	(640)
Accrued expenses and other liabilities	24	(93)
Net cash provided by (used in) operating activities	1,604	(526)
Cash flows from investing activities:
Purchase of property and equipment	(107)	(41)
Net cash used in investing activities	(107)	(41)
Cash flows from financing activities:
Advances under revolving credit facility	9,997	12,556
Repayments of advances under revolving credit facility	(10,768)	(11,881)
Repayments under term note payables	(544)	(372)
Repayments under capitalized lease obligations	(30)	(39)
Net cash (used in) provided by financing activities	(1,345)	264
Net increase (decrease) in cash	152	(303)
Cash at beginning of period	132	395
Cash at end of period	284	92
Supplemental disclosures of cash flow information:
Interest paid	198	195
Income taxes paid		$ 117